Differences in leukocyte phenotype and interferon-gamma expression in stroma and endothelium during corneal graft

Susan M Nicholls1, Sanjiv Banerjee, Francisco C Figueiredo

  • 1Unit of Ophthalmology, Department of Clinical Science at South Bristol, School of Medical Sciences, University Walk, Bristol, BS8 1TD, UK. s.m.nicholls@bris.ac.uk

Insights

Preventing corneal endothelial rejection is vital for transplant success. This study reveals distinct immune cell infiltration patterns in corneal layers, with unique profiles on the endothelium and in the epithelial rejection line.

Area of Science:

  • Ophthalmology
  • Immunology
  • Transplantation Biology

Background:

  • Corneal transplant success hinges on preventing endothelial rejection.
  • Understanding the cellular infiltrate in corneal rejection is limited.

Purpose of the Study:

  • To characterize the immune cell infiltrate in different layers of rejecting rat corneal allografts.
  • To compare endothelial infiltrate with stromal and epithelial infiltrates.

Main Methods:

  • Rat corneal transplantation (LEW to PVG recipients).
  • Monitoring clinical rejection via slit lamp.
  • Flat-mount preparation of corneal layers for cellular analysis at various time points.
  • Flow cytometry to identify immune cell subsets and cytokine production (TNF-alpha, IFN-gamma).

Main Results:

  • Clinical rejection occurred between days 10-15, marked by epithelial and endothelial infiltration.
  • Allografts showed significantly more stromal leukocyte infiltration than isografts.
  • Endothelium showed no infiltration on day 10, but on day 15, macrophages, MHC class II(+), and CD8(+) cells predominated.
  • T cells and NK cells were prominent in the epithelial rejection line.
  • No IFN-gamma-producing cells were found on the endothelium, despite their presence in stroma and epithelium.

Conclusions:

  • Corneal rejection involves distinct immune cell infiltration patterns across different tissue layers.
  • The endothelium exhibits a unique, restricted immune cell profile, notably lacking IFN-gamma.
  • The anterior chamber environment may modulate the anti-endothelial immune response.